Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1

Petra Mooij, Gerrit Koopman, Jan Wouter Drijfhout, Ivonne G. Nieuwenhuis, Niels Beenhakker, Josef Koestler, Willy M J M Bogers, Ralf Wagner, Mariano Esteban, Giuseppe Pantaleo, Jonathan L. Heeney, Bertram Jacobs, Cornelis J M Melief

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The Thai trial (RV144) indicates that a prime–boost vaccine combination that induces both T-cell and antibody responses may be desirable for an effective HIV vaccine. We have previously shown that immunization with synthetic long peptides (SLP), covering the conserved parts of SIV, induced strong CD4 T-cell and antibody responses, but only modest CD8 T-cell responses. To generate a more balanced CD4/CD8 T-cell and antibody response, this study evaluated a poxvector prime/SLP boost strategy in rhesus macaques. Priming with a replication-competent NYVAC, encoding HIV-1 clade C gag, pol and nef, induced modest IFNc T-cell immune responses, predominantly directed against HIV-1 Gag. Booster immunization with SLP, covering the conserved parts of HIV-1 Gag, Pol and Env, resulted in a more than 10-fold increase in IFNc ELISpot responses in four of six animals, which were predominantly HIV-1 Pol-specific. The animals showed a balanced polyfunctional CD4 and CD8 T-cell response and high Ab titres.

Original languageEnglish (US)
Pages (from-to)1478-1483
Number of pages6
JournalJournal of General Virology
Volume96
DOIs
StatePublished - 2015

Fingerprint

Secondary Immunization
Macaca mulatta
Antibody Formation
HIV-1
T-Lymphocytes
Peptides
Combined Vaccines
AIDS Vaccines
Immunization

ASJC Scopus subject areas

  • Virology

Cite this

Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1. / Mooij, Petra; Koopman, Gerrit; Drijfhout, Jan Wouter; Nieuwenhuis, Ivonne G.; Beenhakker, Niels; Koestler, Josef; Bogers, Willy M J M; Wagner, Ralf; Esteban, Mariano; Pantaleo, Giuseppe; Heeney, Jonathan L.; Jacobs, Bertram; Melief, Cornelis J M.

In: Journal of General Virology, Vol. 96, 2015, p. 1478-1483.

Research output: Contribution to journalArticle

Mooij, P, Koopman, G, Drijfhout, JW, Nieuwenhuis, IG, Beenhakker, N, Koestler, J, Bogers, WMJM, Wagner, R, Esteban, M, Pantaleo, G, Heeney, JL, Jacobs, B & Melief, CJM 2015, 'Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1', Journal of General Virology, vol. 96, pp. 1478-1483. https://doi.org/10.1099/vir.0.000074
Mooij, Petra ; Koopman, Gerrit ; Drijfhout, Jan Wouter ; Nieuwenhuis, Ivonne G. ; Beenhakker, Niels ; Koestler, Josef ; Bogers, Willy M J M ; Wagner, Ralf ; Esteban, Mariano ; Pantaleo, Giuseppe ; Heeney, Jonathan L. ; Jacobs, Bertram ; Melief, Cornelis J M. / Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1. In: Journal of General Virology. 2015 ; Vol. 96. pp. 1478-1483.
@article{a2c83503efe04e4fa05813cd390b0a4f,
title = "Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1",
abstract = "The Thai trial (RV144) indicates that a prime–boost vaccine combination that induces both T-cell and antibody responses may be desirable for an effective HIV vaccine. We have previously shown that immunization with synthetic long peptides (SLP), covering the conserved parts of SIV, induced strong CD4 T-cell and antibody responses, but only modest CD8 T-cell responses. To generate a more balanced CD4/CD8 T-cell and antibody response, this study evaluated a poxvector prime/SLP boost strategy in rhesus macaques. Priming with a replication-competent NYVAC, encoding HIV-1 clade C gag, pol and nef, induced modest IFNc T-cell immune responses, predominantly directed against HIV-1 Gag. Booster immunization with SLP, covering the conserved parts of HIV-1 Gag, Pol and Env, resulted in a more than 10-fold increase in IFNc ELISpot responses in four of six animals, which were predominantly HIV-1 Pol-specific. The animals showed a balanced polyfunctional CD4 and CD8 T-cell response and high Ab titres.",
author = "Petra Mooij and Gerrit Koopman and Drijfhout, {Jan Wouter} and Nieuwenhuis, {Ivonne G.} and Niels Beenhakker and Josef Koestler and Bogers, {Willy M J M} and Ralf Wagner and Mariano Esteban and Giuseppe Pantaleo and Heeney, {Jonathan L.} and Bertram Jacobs and Melief, {Cornelis J M}",
year = "2015",
doi = "10.1099/vir.0.000074",
language = "English (US)",
volume = "96",
pages = "1478--1483",
journal = "Journal of General Virology",
issn = "0022-1317",
publisher = "Society for General Microbiology",

}

TY - JOUR

T1 - Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1

AU - Mooij, Petra

AU - Koopman, Gerrit

AU - Drijfhout, Jan Wouter

AU - Nieuwenhuis, Ivonne G.

AU - Beenhakker, Niels

AU - Koestler, Josef

AU - Bogers, Willy M J M

AU - Wagner, Ralf

AU - Esteban, Mariano

AU - Pantaleo, Giuseppe

AU - Heeney, Jonathan L.

AU - Jacobs, Bertram

AU - Melief, Cornelis J M

PY - 2015

Y1 - 2015

N2 - The Thai trial (RV144) indicates that a prime–boost vaccine combination that induces both T-cell and antibody responses may be desirable for an effective HIV vaccine. We have previously shown that immunization with synthetic long peptides (SLP), covering the conserved parts of SIV, induced strong CD4 T-cell and antibody responses, but only modest CD8 T-cell responses. To generate a more balanced CD4/CD8 T-cell and antibody response, this study evaluated a poxvector prime/SLP boost strategy in rhesus macaques. Priming with a replication-competent NYVAC, encoding HIV-1 clade C gag, pol and nef, induced modest IFNc T-cell immune responses, predominantly directed against HIV-1 Gag. Booster immunization with SLP, covering the conserved parts of HIV-1 Gag, Pol and Env, resulted in a more than 10-fold increase in IFNc ELISpot responses in four of six animals, which were predominantly HIV-1 Pol-specific. The animals showed a balanced polyfunctional CD4 and CD8 T-cell response and high Ab titres.

AB - The Thai trial (RV144) indicates that a prime–boost vaccine combination that induces both T-cell and antibody responses may be desirable for an effective HIV vaccine. We have previously shown that immunization with synthetic long peptides (SLP), covering the conserved parts of SIV, induced strong CD4 T-cell and antibody responses, but only modest CD8 T-cell responses. To generate a more balanced CD4/CD8 T-cell and antibody response, this study evaluated a poxvector prime/SLP boost strategy in rhesus macaques. Priming with a replication-competent NYVAC, encoding HIV-1 clade C gag, pol and nef, induced modest IFNc T-cell immune responses, predominantly directed against HIV-1 Gag. Booster immunization with SLP, covering the conserved parts of HIV-1 Gag, Pol and Env, resulted in a more than 10-fold increase in IFNc ELISpot responses in four of six animals, which were predominantly HIV-1 Pol-specific. The animals showed a balanced polyfunctional CD4 and CD8 T-cell response and high Ab titres.

UR - http://www.scopus.com/inward/record.url?scp=84937597034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937597034&partnerID=8YFLogxK

U2 - 10.1099/vir.0.000074

DO - 10.1099/vir.0.000074

M3 - Article

VL - 96

SP - 1478

EP - 1483

JO - Journal of General Virology

JF - Journal of General Virology

SN - 0022-1317

ER -